Patryk Krzeminski
Overview
Explore the profile of Patryk Krzeminski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
294
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pelon M, Krzeminski P, Tracz-Gaszewska Z, Misiewicz-Krzeminska I
Front Pharmacol
. 2024 Mar;
15:1351565.
PMID: 38500772
Multiple myeloma is an incurable cancer that originates from antibody-producing plasma cells. It is characterized by an intrinsic ability to produce large amounts of immunoglobulin-like proteins. The high rate of...
2.
Krzeminski P, Misiewicz-Krzeminska I, Grodzik M, Padzinska-Pruszynska I, Kucharzewska P, Ostrowska A, et al.
Biomed Pharmacother
. 2024 Jan;
170:116090.
PMID: 38169187
Purpose: The aim of the study was to evaluate the effect of silver nanoparticles hydrocolloids (AgNPs) on human corneal epithelial cells. Epithelial cells form the outermost and the most vulnerable...
3.
Fraczek W, Kregielewski K, Wierzbicki M, Krzeminski P, Zawadzka K, Szczepaniak J, et al.
Materials (Basel)
. 2023 Aug;
16(16).
PMID: 37629892
Diamond nanoparticles, also known as nanodiamonds (NDs), exhibit remarkable, awe-inspiring properties that make them suitable for various applications in the field of skin care products. However, a comprehensive assessment of...
4.
Rojas E, Corchete L, de Ramon C, Krzeminski P, Quwaider D, Garcia-Sanz R, et al.
Am J Hematol
. 2022 Feb;
97(6):700-710.
PMID: 35188691
Loss and/or mutation of the TP53 gene are associated with short survival in multiple myeloma, but the p53 landscape goes far beyond. At least 12 p53 protein isoforms have been...
5.
Pankiewicz P, Szybinski M, Kisielewska K, Golebiowski F, Krzeminski P, Rutkowska-Wlodarczyk I, et al.
Pharmaceuticals (Basel)
. 2021 Aug;
14(8).
PMID: 34451801
TrkB is a tyrosine kinase receptor that is activated upon binding to brain-derived neurotrophic factor (BDNF). To date, the search for low-molecular-weight molecules mimicking BDNF's action has been unsuccessful. Several...
6.
Misiewicz-Krzeminska I, de Ramon C, Corchete L, Krzeminski P, Rojas E, Isidro I, et al.
Blood Adv
. 2020 Dec;
4(23):6023-6033.
PMID: 33284947
The search for biomarkers based on the mechanism of drug action has not been thoroughly addressed in the therapeutic approaches to multiple myeloma (MM), mainly because of the difficulty in...
7.
Krzeminski P, Garcia-Sanz R, Gutierrez N
Cell Oncol (Dordr)
. 2020 May;
43(4):743-750.
PMID: 32394351
Purpose: Epigenetic therapies have proven to be clinically effective in several hematological malignancies. Here, we aimed to evaluate the effect of a second-generation DNA demethylation agent, zebularine, on multiple myeloma...
8.
Misiewicz-Krzeminska I, Krzeminski P, Corchete L, Quwaider D, Rojas E, Herrero A, et al.
Noncoding RNA
. 2019 Jan;
5(1).
PMID: 30654527
Intensive research has been undertaken during the last decade to identify the implication of microRNAs (miRNAs) in the pathogenesis of multiple myeloma (MM). The expression profiling of miRNAs in MM...
9.
Quwaider D, Corchete L, Misiewicz-Krzeminska I, Sarasquete M, Perez J, Krzeminski P, et al.
J Hematol Oncol
. 2017 Apr;
10(1):92.
PMID: 28420429
Background: The B cell maturation process involves multiple steps, which are controlled by relevant pathways and transcription factors. The understanding of the final stages of plasma cell (PC) differentiation could...
10.
Herrero A, Rojas E, Misiewicz-Krzeminska I, Krzeminski P, Gutierrez N
Int J Mol Sci
. 2016 Dec;
17(12).
PMID: 27916892
The p53 pathway is inactivated in the majority of human cancers. Although this perturbation frequently occurs through the mutation or deletion of p53 itself, there are other mechanisms that can...